
In the spring, we will participate in the 1st Czechoslovak Congress of Medical Genetics, which will take place from April 2–4, 2025, at the Cultural and Congress Center Elektra in the spa town of Luha...
Read moreVisit us at the 19th edition of the RANK 2025 conference, which will take place on March 19th and 20th at the Zlatá Štika Hotel in Pardubice. The conference is organized by the Czech Society of Clinic...
Read moreWe would like to invite you to the 23rd Kapras Day on the topic of "Clinical Genetics," which will take place on Wednesday, February 26, 2025, in the Congress Hall of Hotel Olšanka in Prague. We loo...
Read moreDescription:
MCLAB’s Tn5 Transposase represents a highly active variant of the Tn5 transposase enzyme. This enzyme facilitates the random insertion of a Tn5 Transposon into target DNA in vitro. Efficient transposition requires the presence of a specific 19-bp transposase recognition sequence (Mosaic End or ME sequence) at each end of the Tn5 Transposon.
The transposition process catalyzed by the Tn5 Transposase involves a multi-step “cut and paste” mechanism. Initially, the enzyme binds to the 19-bp ME of the transposon, forming a complex known as the Transposome. Subsequently, the Transposome initiates random attacks on the phosphodiester backbone of the target DNA, leading to cleavage. Finally, the Tn5 Transposase catalyzes the covalent linkage of the 3′-OH ends of the transposon to the exposed 5′-phosphorylated ends of the target DNA. This transposition event results in the creation of a 9-bp sequence duplication immediately flanking the site of transposon insertion.
Enzyme is supplied at a concentration of 1 U/µL.
Application:
Purified from an E. coli strain carrying the Tn5 gene.
-20°C, avoid repeated free-thaw
10X Tn5 Transposase Reaction Buffer (1 M Tris-acetate (pH 7.5); 3 M potassium acetate; 200 mM magnesium acetate)
10X Tn5 Stop Solution (1% SDS)
100 µL (cat.n. TN5-100)
500 µL (cat.n. TN5-200)